Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: CPAMarty who wrote (276)	2/14/1999 11:21:00 AM
From: JEB	Respond to of 2515

Marty, So why hasn't the company put out a PR on the FDA phase III approval of C225? The only acknowledgement I see is a report for the CR conference. What's the game? Also, what is it with this stock? It hovers around 10. Like a magnet to ferrous steel it wants to go back to the 10 spot. If the market beats it down to 9, it comes back to 10 in a day. If the market wants to take it to 11, the same thing. I'll say this, 10 is one heck of a support level for this stock. Curious action?, JEB